Calvin Sandra 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Calvin Sandra（CIK 1882909）在 1 家公司共报告 20 笔 SEC Form 4 内部人交易（最近一笔 2026-09-17）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 买入 | 1,625 | $33,248 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 卖出 | 4,275 | $265,627 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 卖出 | 800 | $50,278 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 卖出 | 300 | $19,099 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 买入 | 2,500 | $68,750 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 买入 | 1,250 | $28,000 |
| 2026-04-16 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 买入 | 6,500 | $132,990 |
| 2026-04-16 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 买入 | 2,500 | $56,000 |
| 2026-04-16 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 买入 | 6,250 | $55,812 |
| 2026-04-16 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 卖出 | 21,977 | $902,595 |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 买入 | 15,180 | $0 |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 卖出 | 4,333 | $139,176 |
| 2025-12-29 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 卖出 | 7,402 | $296,080 |
| 2025-12-16 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 卖出 | 2,910 | $104,760 |
| 2025-11-06 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 卖出 | 67,115 | $2.4M |
| 2025-11-06 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 买入 | 10,000 | $252,500 |
| 2025-11-06 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 买入 | 17,500 | $470,400 |
| 2025-11-06 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 买入 | 15,000 | $412,500 |
| 2025-11-06 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 买入 | 12,500 | $280,000 |
| 2025-11-06 | Travere Therapeutics, Inc. (TVTX) | SVP, CHIEF ACCOUNTING OFFICER | 买入 | 6,250 | $55,812 |
来源：SEC Form 4 申报文件 · 截至 2026-09-17